New pharmacological strategies for protecting kidney function in type 2 diabetes (vol 7, pg 397, 2018)

被引：0
|
作者：
Muskiet, M. H. A.
Wheeler, D. C.
Heerspink, H. J. L.
机构：
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2019年 / 7卷 / 05期
关键词：
D O I：
10.1016/S2213-8587(19)30035-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E5 / E5
页数：1
相关论文
共 50 条
  • [21] New avenues for the pharmacological management of type 2 diabetes: An update
    Cuny, Thomas
    Guerci, Bruno
    Cariou, Bertrand
    ANNALES D ENDOCRINOLOGIE, 2012, 73 (05) : 459 - 468
  • [22] New pharmacological principles in the therapy of type 2 diabetes mellitus
    Gallwitz, B.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 360 - 360
  • [23] 55-year-old, overweight Patient with Type 2 Diabetes (vol 143, pg 680, 2018)
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2018, 143 (09) : 680 - 681
  • [24] Pharmacologic Glycemic Management of Type 2 Diabetes in Adults (vol 42, pg S88, 2018)
    Lipscombe, Lorraine
    Booth, Gillian
    Butalia, Sonia
    Dasgupta, Kaberi
    Eurich, Dean T.
    Goldenberg, Ronald
    Khan, Nadia
    MacCallum, Lori
    Shah, Baiju R.
    Simpson, Scot
    CANADIAN JOURNAL OF DIABETES, 2018, 42 (05) : 575 - 575
  • [25] Pharmacologic Glycemic Management of Type 2 Diabetes in Adults (vol 42, pg S88, 2018)
    Lipscombe, Lorraine
    Booth, Gillian
    Butalia, Sonia
    Dasgupta, Kaberi
    Eurich, Dean T.
    Goldenberg, Ronald
    Khan, Nadia
    MacCallum, Lori
    Shah, Baiju R.
    Simpson, Scot
    CANADIAN JOURNAL OF DIABETES, 2018, 42 (03) : 336 - 336
  • [26] RETRACTION: Effect of Rosuvastatin on Cholesterol Efflux Capacity and Endothelial Function in Type 2 Diabetes Mellitus and Dyslipidemia (Retraction of Vol 82, Pg 1387, 2018)
    Lim, Soo
    CIRCULATION JOURNAL, 2019, 83 (04) : 948 - 948
  • [27] Kidney hemodynamic function in men and postmenopausal women with type 2 diabetes and preserved kidney function
    van Velzen, Daan M.
    Smits, Mark M.
    van Bommel, Erik J. M.
    Muskiet, Marcel H. A.
    Tonneijck, Lennart
    Kramer, Mark H. H.
    Joles, Jaap A.
    den Heijer, Martin
    Nokoff, Natalie
    Bjornstad, Petter
    van Raalte, Daniel H.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2021, 320 (06) : F1152 - F1158
  • [28] PHARMACOLOGICAL STRATEGIES FOR PREVENTING TYPE 2 DIABETES IN PATIENTS WITH IMPAIRED GLUCOSE TOLERANCE
    Smith-Marsh, D.
    DRUGS OF TODAY, 2013, 49 (08) : 499 - 507
  • [29] Pharmacological Strategies to Reduce Cardiovascular Risk in Type 2 Diabetes MellitusAn Update
    Marcel M. C. Hovens
    Jouke T. Tamsma
    Edith D. Beishuizen
    Menno V. Huisman
    Drugs, 2005, 65 : 433 - 445
  • [30] Pharmacological strategies to reduce cardiovascular risk in type 2 diabetes mellitus - An update
    Hovens, MMC
    Tamsma, JT
    Beishuizen, ED
    Huisman, MV
    DRUGS, 2005, 65 (04) : 433 - 445
12345